Zepp Health (NYSE:ZEPP) Stock Rating Lowered by Wall Street Zen

Zepp Health (NYSE:ZEPP) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Tuesday, Wall Street Zen reports.

Separately, Fundamental Research set a $53.01 price objective on shares of Zepp Health and gave the company a “buy” rating in a research note on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $53.01.

Zepp Health Stock Performance

ZEPP stock opened at $4.98 on Tuesday. The company has a quick ratio of 0.70, a current ratio of 0.90 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $73.11 million, a price-to-earnings ratio of -1.81 and a beta of 1.87. Zepp Health has a 12 month low of $3.85 and a 12 month high of $61.85. The firm has a 50 day moving average of $5.07 and a two-hundred day moving average of $9.78.

Insiders Place Their Bets

In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the sale, the chief financial officer owned 114,539 shares of the company’s stock, valued at $528,024.79. This trade represents a 7.91% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Zepp Health

Hedge funds have recently modified their holdings of the business. UBS Group AG grew its stake in shares of Zepp Health by 16,412.0% in the third quarter. UBS Group AG now owns 181,302 shares of the company’s stock worth $8,300,000 after acquiring an additional 180,204 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new position in Zepp Health during the 3rd quarter valued at $1,895,000. Lighthouse Investment Partners LLC bought a new stake in Zepp Health in the 3rd quarter valued at $2,070,000. Millennium Management LLC bought a new stake in Zepp Health in the 3rd quarter valued at $11,265,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in Zepp Health in the 3rd quarter worth $43,000. 52.61% of the stock is owned by institutional investors.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.